Advertise with us
[January 24, 2013]
Cellulitis - Pipeline Review, H2 2012 - Latest News and Deals
Jan 24, 2013 (M2 PRESSWIRE via COMTEX) -- Research and Markets (
) has announced the addition of Global Markets Direct's new report "Cellulitis - Pipeline Review, H2 2012" to their offering.
Global Markets Direct's, 'Cellulitis - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Cellulitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cellulitis. Cellulitis - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Scope - A snapshot of the global therapeutic scenario for Cellulitis.
- A review of the Cellulitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Cellulitis pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Key Topics Covered: - List of Tables - List of Figures - Introduction - Report coverage - Cellulitis Overview - Therapeutics Development - An Overview of Pipeline Products for Cellulitis - Cellulitis Therapeutics under Development by Companies - Cellulitis Therapeutics under Investigation by Universities/Institutes - Late Stage Products - Comparative Analysis - Mid Clinical Stage Products - Comparative Analysis - Cellulitis Therapeutics - Products under Development by Companies - Cellulitis Therapeutics - Products under Investigation by Universities/Institutes - Companies Involved in Cellulitis Therapeutics Development - Trius Therapeutics, Inc.
- Durata Therapeutics Inc.
- Cellulitis - Therapeutics Assessment - Assessment by Monotherapy Products - Assessment by Combination Products - Assessment by Route of Administration - Assessment by Molecule Type - Drug Profiles - Cellulitis Therapeutics - Drug Profile Updates - Cellulitis Therapeutics - Dormant Products - Appendix - Methodology - Coverage - Secondary Research - Primary Research - Expert Panel Validation For more information visit
Source: Global Markets Direct CONTACT: Research and Markets, Laura Wood, Senior Manager.
email@example.com Fax from USA: 646-607-1907 Fax from rest of the world: +353-1-481-1716 Sector: Infectious Diseases (
cat_id=121&campaign_id=t9l8cw) ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at
on the world wide web. Inquiries to firstname.lastname@example.org.
Back To NFVZone's Homepage